Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities IBRX - ImmunityBio, Inc.
-30.5 M
LAST VALUE
40.09%
2 YEAR CAGR
-8.93%
5 YEAR CAGR
-151.58%
10 YEAR CAGR